Aug 01, 2022 05:22 PM IST

Neutral Torrent Pharma; target of Rs 1510: Motilal Oswal

Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 1510 in its research report dated July 30, 2022.

Torrent Pharma Standalone June 2022 Net Sales at Rs 1,933.00 crore, up 14.04% Y-o-Y

Torrent Pharma Consolidated June 2022 Net Sales at Rs 2,347.00 crore, up 9.98% Y-o-Y

Torrent Pharma Q1 net up 7% at Rs 354 crore

The drug firm had posted a net profit of Rs 330 crore in the April-June period of the last fiscal.

Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct

Net Sales are expected to increase by 11 percent Y-o-Y (up 11.1 percent Q-o-Q) to Rs 2,367.8 crore, according to ICICI Direct.

Torrent Pharma acquires four brands from Dr Reddy’s Lab

According to the terms of the definitive agreement, Torrent Pharma will take over the manufacturing, marketing and distribution of these brands in India.

Torrent Pharma jumps 6% as board issues bonus share, Credit Suisse expects 24% upside

The company has also declared a final dividend of Rs 23 (460 percent) per share of Rs 5 each including special dividend of Rs 15 per share.

Torrent Pharma Consolidated March 2022 Net Sales at Rs 2,131.00 crore, up 10.02% Y-o-Y

Torrent Pharma Standalone March 2022 Net Sales at Rs 1,662.00 crore, up 13.22% Y-o-Y

Torrent Pharma posts Rs 118 crore Q4 loss on impairment provision

Torrent Pharma announced on Wednesday that its consolidated loss for the fourth quarter ended March 2022 was Rs 118 crore, owing to an impairment charge of Rs 425 crore relating to the cessation of its liquids business in the United States.

Torrent Pharma shares shed 15% on poor Q3 show; global brokerage downgrades stock

Margin should recover in the two quarters, driven by price hikes in India and Brazil adding that India outlook remains strong, which keeps us constructive on the stock, CLSA said

Torrent Pharma Consolidated December 2021 Net Sales at Rs 2,108.00 crore, up 5.66% Y-o-Y

Torrent Pharma Standalone December 2021 Net Sales at Rs 1,588.00 crore, down 1.73% Y-o-Y

Torrent Pharma recalls over 27,000 bottles of blood pressure lowering drug in US

The affected lot has been produced in India and later the company has supplied to its US-based subsidiary for distribution in the US, the world’s largest market for generic drugs.

Torrent Pharma Consolidated September 2021 Net Sales at Rs 2,137.00 crore, up 5.95% Y-o-Y

Torrent Pharma Standalone September 2021 Net Sales at Rs 1,799.00 crore, up 9.7% Y-o-Y

Torrent Pharma Q2 consolidated net up 2% at Rs 316 crore

The drug maker had reported a net profit of Rs 310 crore in the July-September period of last fiscal.

Torrent Pharma Consolidated June 2021 Net Sales at Rs 2,134.00 crore, up 3.79% Y-o-Y

Torrent Pharma Standalone June 2021 Net Sales at Rs 1,695.00 crore, down 1.85% Y-o-Y

Torrent Pharma Q1 PAT seen up 34.2% YoY to Rs 430.8 cr: KRChoksey

Net Sales are expected to decrease by 5.8 percent Y-o-Y to Rs 1,837 crore, according to KRChoksey.

Torrent Pharma Q1 PAT seen up 10.8% YoY to Rs 355.7 cr: ICICI Direct

Net Sales are expected to increase by 7.7 percent Y-o-Y (up 14.3 percent Q-o-Q) to Rs 2,214.3 crore, according to ICICI Direct.

Torrent Pharma Consolidated March 2021 Net Sales at Rs 1,937.00 crore, down 0.46% Y-o-Y

What should investors do with Torrent Pharma post Q4; buy, sell or hold?

Earnings before interest, tax, depreciation and amortization (EBITDA) was up 6.2 percent at Rs 582 crore and margin was at 30 percent.

Torrent Pharma Q4 PAT may dip 1.9% YoY to Rs. 308 cr: Sharekhan

Net Sales are expected to increase by 4.6 percent Y-o-Y (up 1.5 percent Q-o-Q) to Rs. 2,000.7 crore, according to Sharekhan.

Torrent Pharma Consolidated December 2020 Net Sales at Rs 1,995.00 crore, up 1.48% Y-o-Y